Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/72732
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Federico, M. | en_US |
| dc.contributor.author | Perez Fustero, A. | en_US |
| dc.contributor.author | Catarina, C. | en_US |
| dc.contributor.author | Fernandez, I. | en_US |
| dc.contributor.author | Perez Molina, J. L. | en_US |
| dc.contributor.author | Morales Orue, I. | en_US |
| dc.contributor.author | Lloret Sáez-Bravo, Marta | en_US |
| dc.date.accessioned | 2020-05-22T09:16:55Z | - |
| dc.date.available | 2020-05-22T09:16:55Z | - |
| dc.date.issued | 2019 | en_US |
| dc.identifier.issn | 0167-8140 | en_US |
| dc.identifier.other | WoS | - |
| dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/72732 | - |
| dc.description.abstract | Purpose or Objective: Intracavitary/interstitial (IC/IS) brachytherapy (BT) improves HRCTV dose coverage in large locally advanced tumors resulting in improved local control and survival. In small tumors IC/IS brachytherapy may be useful in selected situations due to difficult OAR/tumor topography. A prospective trial was designed in order to evaluate in a series of consecutive patients with small cervical tumors potential gains of IC/IS vs. Intracavitary (IC) brachytherapy | en_US |
| dc.language | eng | en_US |
| dc.relation.ispartof | Radiotherapy and Oncology | en_US |
| dc.source | Radiotherapy And Oncology [ISSN 0167-8140], v. 133 sup. 1, p. S85-S86, (Abril 2019) | en_US |
| dc.subject | 320111 Radiología | en_US |
| dc.title | Dosimetric comparison of T-O brachytherapy with/without interstitial component in FIGO I-IIB tumors | en_US |
| dc.type | info:eu-repo/semantics/conferenceObject | en_US |
| dc.type | ConferenceObject | en_US |
| dc.relation.conference | 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) | en_US |
| dc.identifier.doi | 10.1016/S0167-8140(19)30593-6 | en_US |
| dc.identifier.isi | 000468315600157 | - |
| dc.identifier.eissn | 1879-0887 | - |
| dc.description.lastpage | S86 | en_US |
| dc.description.firstpage | S85 | en_US |
| dc.relation.volume | 133 | en_US |
| dc.investigacion | Ciencias de la Salud | en_US |
| dc.type2 | Actas de congresos | en_US |
| dc.contributor.daisngid | 2129395 | - |
| dc.contributor.daisngid | 30211064 | - |
| dc.contributor.daisngid | 23147274 | - |
| dc.contributor.daisngid | 6447172 | - |
| dc.contributor.daisngid | 29053950 | - |
| dc.contributor.daisngid | 30204855 | - |
| dc.contributor.daisngid | 802813 | - |
| dc.description.numberofpages | 2 | en_US |
| dc.utils.revision | Sí | en_US |
| dc.contributor.wosstandard | WOS:Federico, M | - |
| dc.contributor.wosstandard | WOS:Fustero, AP | - |
| dc.contributor.wosstandard | WOS:Catarina, C | - |
| dc.contributor.wosstandard | WOS:Fernandez, I | - |
| dc.contributor.wosstandard | WOS:Molina, JLP | - |
| dc.contributor.wosstandard | WOS:Orue, IM | - |
| dc.contributor.wosstandard | WOS:Lloret, M | - |
| dc.date.coverdate | Abril 2019 | en_US |
| dc.identifier.supplement | 1 | - |
| dc.identifier.conferenceid | events121155 | - |
| dc.identifier.ulpgc | Sí | es |
| dc.description.sjr | 2,003 | |
| dc.description.jcr | 4,856 | |
| dc.description.sjrq | Q1 | |
| dc.description.jcrq | Q1 | |
| dc.description.scie | SCIE | |
| item.grantfulltext | none | - |
| item.fulltext | Sin texto completo | - |
| crisitem.author.dept | Departamento de Ciencias Clínicas | - |
| crisitem.author.fullName | Lloret Sáez-Bravo, Marta | - |
| crisitem.event.eventsstartdate | 26-04-2019 | - |
| crisitem.event.eventsenddate | 30-04-2019 | - |
| Appears in Collections: | Actas de congresos | |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.